Alnylam Pharmaceuticals | ALNY - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 11.33 1.25 2026-06
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 18.07 1.77 2026-06
Arrowhead Research 39.19 0 2026-06
BioCryst Pharmaceuticals 6.84 0.78 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 21.36 3.57 2026-03
PTC Therapeutics 8.76 1.22 2026-03
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Sanofi 20.87 5.12 2026-03
Sarepta Therapeutics 27.27 0 2026-03
Takeda 24.4 22.12 2026-06
Tectonic Therapeutic 4.01 0.63 2024-03
Vertex Pharmaceuticals 28.05 2.22 2026-06
Xencor 29.92 3.22 2022-09